RENAISSANCE TECHNOLOGIES LLC – Neurocrine Biosciences, Inc. Transaction History
RENAISSANCE TECHNOLOGIES LLC portfolio value:
$153.20M
portfolio value
RENAISSANCE TECHNOLOGIES LLC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.45% | -6.55K shares | 11.95M | $106.21 | 1.44M |
| Q2 2022 | share | Increase | +13.19% | 168.9K shares | 21.23M | $97.48 | 1.44M |
| Q1 2022 | share | Decrease | -10.08% | -143.54K shares | -1.24M | $93.75 | 1.28M |
| Q4 2021 | share | Increase | +4.99% | 67.7K shares | -8.79M | $84.63 | 1.42M |
| Q3 2021 | share | Increase | +9.11% | 113.24K shares | 9.10M | $95.91 | 1.35M |
| Q2 2021 | share | Decrease | -11.10% | -155.14K shares | -15M | $97.32 | 1.24M |
| Q1 2021 | share | Decrease | -22.65% | -409.32K shares | -37.27M | $97.25 | 1.39M |
| Q4 2020 | share | Decrease | -15.92% | -342.27K shares | -33.47M | $95.85 | 1.80M |
| Q3 2020 | share | Increase | +44.77% | 664.7K shares | 25.55M | $96.16 | 2.14M |
| Q2 2020 | share | Increase | +106.39% | 765.38K shares | 118.87M | $122 | 1.48M |
| Q1 2020 | share | Decrease | -2.68% | -19.79K shares | -17.19M | $86.55 | 719.38K |
| Q4 2019 | share | Increase | +18853.13% | 735.27K shares | 79.10M | $107.49 | 739.17K |
| Q3 2019 | share | Decrease | -74.41% | -11.34K shares | -936K | $90.11 | 3.9K |
| Q2 2019 | share | Decrease | -93.31% | -212.7K shares | -18.79M | $84.43 | 15.24K |
| Q1 2019 | share | Increase | +200.55% | 152.1K shares | 14.66M | $88.1 | 227.94K |
| Q4 2018 | share | Increase | 0.00% | 75.84K shares | 5.41M | $71.41 | 75.84K |
| Q2 2018 | share | Decrease | -100.00% | -162.34K shares | -13.46M | $98.24 | 0 |
| Q1 2018 | share | Decrease | -58.08% | -224.9K shares | -16.58M | $82.93 | 162.34K |
| Q4 2017 | share | Increase | 0.00% | 387.24K shares | 30.04M | $77.59 | 387.24K |